Stacie Dusetzina, PhD, was among nine experts from across the country invited to participate in a listening session July 8 in Washington, D.C. with Seema Verma, administrator for the Centers for Medicare and Medicaid Services on payment strategies for new and innovative high-cost prescription drugs.
The administration of President Donald Trump has made the issue of prescription drug prices a public priority in recent weeks as more research is published that illustrates the difficulty many Americans have paying for prescription drugs.
Among that research is Dusetzina’s recent study, published July 1 in Health Affairs, that shows how some Medicare beneficiaries are paying more for specialty generic drugs than brand-name counterparts.
Read that Health Affairs study here.
See all the department faculty’s recent research here.